Author

Stephen D. Mikolajczyk

Observed names: S D Mikolajczyk, S Mikolajczyk, S. D. Mikolajczyk, S. Mikolajczyk, STEPHEN D. MIKOLAJCZYK, Stephan D. Mikolajczyk, Stephen D Mikolajczyk, Stephen Mikolajczyk

Observed institutions: Mayo Clinic, The University of Texas MD Anderson Cancer Center, Johns Hopkins University, Eli Lilly (United States), Universität Innsbruck, Washington University in St. Louis, Johns Hopkins Medicine, University of California San Diego, Dongguk University Ilsan Hospital, Beckman Coulter (United States)

OpenAlex ID: A5109553780

Human Kallikrein 2 (hK2) and Prostate-Specific Antigen (PSA): Two Closely Related, but Distinct, Kallikreins in the Prostate

1998 · Harry G. Rittenhouse, Judith A. Finlay, et al. · Critical Reviews in Clinical Laboratory Sciences · 299

Detection of EpCAM-Negative and Cytokeratin-Negative Circulating Tumor Cells in Peripheral Blood

2011 · Stephen D. Mikolajczyk, Lisa S. Millar, et al. · Journal of Oncology · 253

PDF

A Novel Platform for Detection of CK+ and CK− CTCs

2011 · Chad V. Pecot, Farideh Z. Bischoff, et al. · Cancer Discovery · 215

Expression of pro form of prostate-specific antigen by mammalian cells and its conversion to mature, active form by human kallikrein 2.

1997 · A Kumar, S D Mikolajczyk, et al. · PubMed · 194

A truncated precursor form of prostate-specific antigen is a more specific serum marker of prostate cancer.

2001 · S D Mikolajczyk, K M Marker, et al. · PubMed · 191

Free prostate-specific antigen in serum is becoming more complex

2002 · Stephen D Mikolajczyk, Leonard S Marks, et al. · Urology · 190

A precursor form of prostate-specific antigen is more highly elevated in prostate cancer compared with benign transition zone prostate tissue.

2000 · S D Mikolajczyk, L S Millar, et al. · PubMed · 184

Serum Pro Prostate Specific Antigen Improves Cancer Detection Compared to Free and Complexed Prostate Specific Antigen in Men With Prostate Specific Antigen 2 to 4 Ng/Ml

2003 · WILLIAM J. CATALONA, GEORG BARTSCH, et al. · The Journal of Urology · 168

“BPSA,” a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia

2000 · Stephen D Mikolajczyk, Lisa S Millar, et al. · Urology · 167

Serum Pro-prostate Specific Antigen Preferentially Detects Aggressive Prostate Cancers in Men With 2 to 4 Ng/ml Prostate Specific Antigen

2004 · WILLIAM J. CATALONA, GEORG BARTSCH, et al. · The Journal of Urology · 160

A precursor form of PSA (pPSA) is a component of the free PSA in prostate cancer serum

1997 · Stephen D. Mikolajczyk, Lana S. Grauer, et al. · Urology · 160

Proenzyme Forms of Prostate-Specific Antigen in Serum Improve the Detection of Prostate Cancer

2004 · Stephen D Mikolajczyk, William J Catalona, et al. · Clinical Chemistry · 153

Proenzyme psa for the early detection of prostate cancer in the 2.5–4.0 ng/ml total psa range: preliminary analysis

2003 · Lori J Sokoll, Daniel W Chan, et al. · Urology · 121

Human Tissue Kallikrein 5 Is a Member of a Proteolytic Cascade Pathway Involved in Seminal Clot Liquefaction and Potentially in Prostate Cancer Progression

2006 · Iacovos P. Michael, Georgios Pampalakis, et al. · Journal of Biological Chemistry · 114

PDF

Benign Prostate-specific Antigen (BPSA) in Serum Is Increased in Benign Prostate Disease

2003 · Harry J Linton, Leonard S Marks, et al. · Clinical Chemistry · 111

Twenty Years of PSA: From Prostate Antigen to Tumor Marker.

2007 · Gabriela De Angelis, Harry G Rittenhouse, et al. · Europe PMC (PubMed Central) · 92

Pro PSA: a more cancer specific form of prostate specific antigen for the early detection of prostate cancer.

2003 · Stephen D. Mikolajczyk, Harry G. Rittenhouse · The Keio Journal of Medicine · 87

PDF

Evaluation of Proprostate Specific Antigen for Early Detection of Prostate Cancer in Men With a Total Prostate Specific Antigen Range of 4.0 to 10.0 Ng/Ml

2003 · MASOOD A. KHAN, ALAN W. PARTIN, et al. · The Journal of Urology · 86

Prostatic human kallikrein 2 inactivates and complexes with plasminogen activator inhibitor-1

1999 · Stephen D. Mikolajczyk, Lisa S. Millar, et al. · International Journal of Cancer · 83

PDF

FISH-based determination of HER2 status in circulating tumor cells isolated with the microfluidic CEE™ platform

2011 · Julie Ann Mayer, Tam Pham, et al. · Cancer Genetics · 80

Are multiple markers the future of prostate cancer diagnostics?

2004 · Stephen D. Mikolajczyk, Yong Song, et al. · Clinical Biochemistry · 79

Changes in the glutathione thiol-disulfide status of Neurospora crassa conidia during germination and aging

1975 · R C Fahey, S Brody, et al. · Journal of Bacteriology · 79

PDF

Serum BPSA outperforms both total PSA and free PSA as a predictor of prostatic enlargement in men without prostate cancer

2004 · Eduardo I. Canto, Herb Singh, et al. · Urology · 69

Immunohistochemical staining of prostate cancer with monoclonal antibodies to the precursor of prostate-specific antigen

2003 · Theresa Y Chan, Stephen D Mikolajczyk, et al. · Urology · 69

Prostate-specific antigen test in diagnostic evaluation of chronic prostatitis/chronic pelvic pain syndrome

2006 · Robert B. Nadler, Mary McNaughton Collins, et al. · Urology · 67

Works count: 76

Citation count: 4,529

H-index: 39

I10-index: 53